Sympathetic-leptin relationship in obesity: effect of weight loss

Metabolism: Clinical and Experimental

Volumn 57, Issue 4, 2008, Pages 555-562

  Quilliot, Didier ^a,b   Böhme, Philip ^b   Zannad, Faiez ^a   Ziegler, Olivier ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Ctr Hospitalier Univ de Nancy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PLACEBO; SIBUTRAMINE;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETITIAN; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION; WEIGHT REDUCTION;

ADULT; BLOOD PRESSURE; BODY COMPOSITION; FEMALE; HEART RATE; HUMANS; LEPTIN; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; SYMPATHETIC NERVOUS SYSTEM; WEIGHT LOSS;

EID: 40049089127     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.11.020     Document Type: Article

References (30)

1. Caro J.F., Sinha M.K., Kolaczynski J.W., et al. Leptin: the tale of an obesity gene. Diabetes 45 (1996) 1455-1462
2. Collins S., Kuhn C.M., Petro A.E., et al. Role of leptin in fat regulation. Nature 380 (1996) 677
3. Kokot F., Adamczak M., Wiecek A., et al. Does leptin play a role in the pathogenesis of essential hypertension?. Kidney Blood Press Res 22 (1999) 154-160
4. Hirose H., Saito I., Tsujioka M., et al. The obese gene product, leptin: possible role in obesity-related hypertension in adolescents. J Hypertens 16 (1998) 2007-2012
5. Shek E.W., Brands M.W., and Hall J.E. Chronic leptin infusion increases arterial pressure. Hypertension 31 (1998) 409-414
6. Correia M.L., Haynes W.G., Rahmouni K., et al. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51 (2002) 439-442
7. Haynes W.G., Morgan D.A., Walsh S.A., et al. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100 (1997) 270-278
8. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
9. Friedewald W.T., Levy R.I., and Frederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
10. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17 (1996) 354-831
11. Pagani M., Mazzuero G., Ferrari A., et al. Sympathovagal interaction during mental stress. A study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation 83 (1991) II43-II51
12. Paolisso G., Manzella D., Montano N., et al. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 85 (2000) 1810-1814
13. Grassi G., Seravalle G., Colombo M., et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97 (1998) 2037-2042
14. Verwaerde P., Sénard J.M., Galinier M., et al. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs. J Hypertens 17 (1999) 1135-1143
15. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24 (2001) 1793-1798
16. Chan J.L., Mietus J.E., Raciti P.M., et al. Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans. Clin Endocrinol (Oxf) 66 (2007) 49-57
17. van Baak M.A. The peripheral sympathetic nervous system in human obesity. Obes Rev 2 (2001) 3-14
18. Stephens T.W., and Caro J.F. To be lean or not to be lean. Is leptin the answer?. Exp Clin Endocrinol Diabetes 106 (1998) 1-15
19. Corry D.B., and Tuck M.L. Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1 (1999) 119-126
20. Adamczak M., Kokot F., and Wiecek A.W. Relationship between plasma renin profile and leptinaemia in patients with essential hypertension. J Hum Hypertens 14 (2000) 503-509
21. Masuo K. Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin. Curr Hypertens Rep 4 (2002) 112-118
22. Rahmouni K., Haynes W.G., Morgan D.A., et al. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 39 (2002) 486-490
23. Ozata M., Ozdemir I.C., and Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84 (1999) 3686-3695
24. Spraul M., Ravussin E., Fontvieille A.M., et al. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92 (1993) 1730-1735
25. Quilliot D., Fluckiger L., Zannad F., et al. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res 11 (2001) 79-86
26. Scarpace P.J., and Tumer N. Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav 74 (2001) 721-727
27. Haynes W.G., Sivitz W.I., Morgan D.A., et al. Sympathetic and cardiorenal actions of leptin. Hypertension 30 (1997) 619-623
28. Gunduz Z., Dursun N., Akgun H., et al. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats. Regul Pept 132 (2005) 59-66
29. Robert D., Brook M., Bard R.L., Bodary P.F., et al. Blood pressure and vascular effects of leptin in humans. Metab Syndr Relat Dis 5 (2007) 63-68
30. Matsumoto T., Miyatsuji A., Miyawaki T., et al. Potential association between endogenous leptin and sympatho-vagal activities in young obese Japanese women. Am J Hum Biol 15 (2003) 8-15